Insider Purchases: Inside the Buy
Tag: defensive stocks
Conagra (CAG): 9% Yield Bargain or Value Trap? 🥫📉
Conagra (CAG) is down big, insiders are buying, and the dividend is near 9%. Is this a deep-value opportunity—or a trap in disguise? 🥫
The “WTW” Strategy Scorecard: Why the Smart Money Is Huddled Here
Willis Towers Watson isn’t a hype stock—it’s a fortress. With insider buying, 100%+ institutional ownership, surging margins, and massive buybacks, WTW is quietly becoming one of the smartest “sleep-well” investments of 2026.
Band-Aids & Bottom Lines: Why Kimberly-Clark’s 5% Yield Is the Ultimate Turnaround Play
KMB isn’t flashy—but it might be one of 2026’s sneakiest high-yield turnarounds. A $1M insider buy, heavy institutional ownership, and a big strategic pivot (hello, Tylenol & Band-Aids via Kenvue) have the market nervous… and contrarians intrigued.
CEO Purchases Abbott Shares, But the Stock Carries Risks
Abbott’s CEO just stepped in with a $2M insider buy — analysts are bullish, shorts are scarce, and institutions remain locked in. Tempting? Yes. Risk-free? Not quite.
A Director Bought Shares of Coca-Cola (KO) Hoping They’ll Sparkle; Should You—Or Will They Fizzle Out?
A fresh insider buy from new director Max Levchin adds fizz to Coca-Cola’s already solid fundamentals: mid-single-digit organic growth, fortress cash flow, and a Dividend King pedigree. We break down the bull/bear case, valuation, and why KO still shines—especially on dips.